DOCSLIB.ORG

Medication Codes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medication Codes CODE Medication Name CODE Medication Name 1779 ABILIFY 0044 ALLBEE T 0001 ABSORBASE 0045 ALLEGRA 0002 ACARBOSE 1750 ALLEREST 0003 ACCOLATE 0046 ALLERGAN HYDROCARE 0004 ACCUPRIL 0047 ALLOPURINOL TABS 0005 ACEBUTOLOL 0048 ALMEBEX 0006 ACETAMINOPHEN 1781 ALOCRIL 0007 ACETAZOLAMIDE 0049 ALOE CAPSULES 0008 ACETEBRIL 0050 ALOE GRANDE CREME 1546 ACETIC ACID IN PROPY 0051 ALOE VERA 0009 ACETIC ACID OTIC 0052 ALOMIDE 1547 ACETOHEXAMIDE 0053 ALOR 1780 ACETYL CARNITINE 0054 ALPHA CF 0010 ACETYLCYSTEINE 0055 ALPHA LIPOLIC ACID 0011 ACIDOPHILUS 0056 ALPHAGAN 0012 ACIPHEX 1552 ALPHAGAN P 0013 ACLOVATE 0057 ALPRAZOLAM 0014 ACTIFED 0058 ALT 0015 ACTIGALL 0059 ALTACE 1749 ACTIQ 0060 ALUPENT 1548 ACTIVELLA (HORMONE) 0061 AMANTADINE HCL 1549 ACTONEL 0062 AMARYL 0016 ACTOS 0063 AMBIEN 0017 ACTRON 0064 AMBROTOSE 0018 ACULAR 0065 AMEBAN 0019 ACUTRIM 0066 AMEN 0020 ACYCLOVIR 0067 AMERGE 0021 ADALAT CC 1553 AMIBID DM 0022 ADAVITE 0068 AMILORIDE HCL 0023 ADLERIKA 0069 AMINO ACID 1550 ADVAIR 0070 AMIODARONE 0024 ADVIL 0071 AMITRIPTYLINE HCL 0025 AEROBID 1554 AMLACTIN 0026 AEROSOL OT 0072 AMLODIPINE BESYLATE 1815 AFEDITAB CR 0073 AMOXAPINE 0027 AGGRENOX 0074 AMOXICILLIN 0028 AGRYLIN 1740 AMOXIL 0029 AKARPINE 0075 AMPICILLIN 1816 AKINETON 0076 ANACIN 0030 ALATONE 0077 ANAFRANIL 0031 ALBUTEROL 1555 ANALGESIC 0032 ALCON 0078 ANAPROX 0033 ALDACTAZIDE 1782 ANEMAGEN 0034 ALDACTONE 0079 ANSAID 0035 ALDOMET 0080 ANTACID CALCIUM 0036 ALENDRONATE 0081 ANTIOX 1551 ALESSE 0082 ANTIVERT 0037 ALEVE 0083 ANUMED HC 0038 ALFALFA 1751 ANUSOL 0039 ALFALIPIC ACID 0084 APAP 0040 ALGIN-ALL 0085 APAP CAPLET 0041 ALKA-SELTZER 0086 APAP WITH CODEINE 0042 ALL PURPOSE VITAMINS 1752 APPLE CIDER VINEGAR 0043 ALLBEE 0087 APRESOLINE NIA/NINR-REACH II All rights reserved (V1.30) Med-list 11/23/04 Page 1 of 18 CODE Medication Name CODE Medication Name 0088 AQUAPHOR 0132 BACTRIM DS 0089 ARAVA 0133 BACTROBAN 0090 ARICEPT 0134 BAYCOL 0091 ARIMIDEX 0135 BAYER ASPIRIN 0092 ARMOUR THYROID 0136 BC TABLETS 0093 ARTANE 0137 BECLOMETHASONE DIPROPIONATE 0094 ARTHRITIS PAIN FORMULA 0138 BECLOVENT 1818 ARTHROPAN 0139 BECONASE AQ NASAL SPRAY 0095 ARTHROTEC 0140 BEDOYECTA 0096 ARTIFICIAL TEARS 0141 BEE POLLEN 0097 ASA 0142 BELBUTAL 0098 ASACOL 0143 BELLADONNA ALKALOIDS 0099 ASCORBIC ACID 0144 BENADRYL 0100 ASCRIPTIN 0145 BENADRYL CREAM 0101 ASENDIN 0146 BENAZEPRIL HCL 0102 ASPARTIC ACID 1785 BENECAR 0103 ASPIRIN 1561 BENEFIBER 0104 ASTELIN NASAL SPRAY 0147 BENTYL 0105 ASULFADINE 0148 BENZONATATE 1556 ATACAND 0149 BENZTROPINE MESYLATE 1557 ATACAND HCL 0150 BEROCCA PLUS TABLETS 0106 ATACANT 0151 BERPLEX PLUS 0107 ATARAX 0152 BETA CAROTENE 0108 ATENOLOL 0153 BETADINE VAGINAL GEL 0109 ATIVAN 0154 BETAGAN LIQUIFILM 0110 ATORVASTATIN 0155 BETAMETHASONE 0111 ATORVASTATIN CALCIUM 0156 BETAPACE 0112 ATROHIST 0157 BETAXOLOL HCL 0113 ATROPINE SULFATE 0158 BETHNECHOL CHLORIDE 0114 ATROVENT 0159 BETIMOL 0115 AUGMENTIN 0160 BETOPIC 1558 AVALIDE 0161 BETOPTIC 1783 AVANDAMET 1562 BEXTRA (VALDECOXIB) 0116 AVANDIA 0162 BIAXIN FILMTABS 0117 AVAPRO 1563 BIDEX 0118 AVEENO 0163 BILBERRY 1753 AVELOX 0164 BIOCAL 1559 AVIANE 0165 BIO-FLAVENOIDS 1819 AVODART 1564 BIO-GEST 0119 AVONEX 0166 BIOMAX VITAMINS 0120 AXID 0167 BIOTIN 1784 AXURA 0168 BISACODYL 0121 AYGESTIN 1820 BISOLVEX 0122 AYTINAL 1755 BISOPROLOL 0123 AZATHIOPRINE 0169 BLACK COHASH 0124 AZITHROMYCIN 0170 BLEPHAMIDE 0125 AZMACORT 0171 BLUE GREEN ALGAE 0126 AZOPT 0172 BOLAX 0127 AZULFIDINE 0173 BONE UP 0128 B PLEX 0174 BONEMEAL 1560 BABY ASPIRIN 0175 BORAGE OIL 0129 BACITRACIN 1786 BORON 3 0130 BACLOFEN 0176 BREWERS YEAST 0131 BACTICORT 0177 BRIMONIDINE TARTRATE NIA/NINR-REACH II All rights reserved (V1.30) Med-list 11/23/04 Page 2 of 18 CODE Medication Name CODE Medication Name 0178 BROMELAINS 0221 CARDURA 0179 BROMOCRIPTINE MESYLATE 0222 CARISOPRODOL 0180 BROMOPHEN 0223 CARPROFEN 0181 BROMOPHEN TD 0224 CARTIA 0182 BRONCHOLATE CAPSULES 0225 CARTIA XT 0183 BRONTEX 1821 CARVEDILOL 0184 BUDESONIDE 0226 CASANTHRANOL 1787 BUFFERED ASPIRIN 0227 CASCARA SAGRADA 0185 BUFFERIN 0228 CASODEX 0186 BUMETANIDE 0229 CASTOR OIL 0187 BUMEX 0230 CATAFLAM 0188 BUPROPION HCL 0231 CATAPRES 0189 BUSPAR 1877 CAT'S CLAW 0190 BUSPIRONE HCL 0232 C-COMPLEX 0191 BUTALBITAL 1822 CDP-CHOLINE 0192 CAFERGOT 0233 CEFACLOR 1565 CAL MAG ZINC 1569 CEFADROXIL 0193 CAL-1000 0234 CEFOL FILMTAB 0194 CALAN SR 1823 CEFPODOXIME 0195 CALCI-CHEW 0235 CEFTIN 1756 CALCIFEROL 1570 CEFUROXIME 0196 CALCIMATE 0236 CEFZIL 0197 CALCITONIN SPRAY 0237 CELEBREX 0198 CALCITRIOL 0238 CELECOX IB 0199 CALCIUM 0239 CELEXA 1886 CALCIUM & D 0240 CELEXA CITALOPRAM HB 0200 CALCIUM ACETATE 0241 CELLCEPT 1758 CALCIUM ASCORBATE 0242 CELLUVISC 0201 CALCIUM CARBONATE 0243 CELONTIN 1566 CALCIUM CITRATE 1571 CENESTIN 1757 CALCIUM COMBINATION 0244 CENTRA VITAMIN 1759 CALCIUM PHOSPHATE 0245 CENTRAX 1567 CALCIUM PLUS 0246 CENTROVITE 0202 CALCIUM POLYCARBOPHI 0247 CENTRUM 1568 CAL-MAG 1572 CENTRUM SILVER 0203 CALMOL 4 0248 CENTURY SENIOR 1788 CALMS FORTE 1824 CEPHADYN 0204 CALM-X 0249 CEPHALEXIN 0205 CALTRATE 600 0250 CEREBYX 0206 CAM-AP-ES 0251 CERTA VITE 0207 CAPITROL CREAM SHAMP 1760 CERTAGEN 0208 CAPOTEN 0252 CHELATED CALCIUM MAGNESIUM 0209 CAPSAICIN 0253 CHEMSTRIP BG 0210 CAPSIN 0254 CHIMARA 0211 CAPTOPRIL 0255 CHLOR-4 0212 CARAFATE 0256 CHLORACOL 0213 CARBAMAZEPINE 0257 CHLORAL HYDRATE 0214 CARBARSONE 1573 CHLORASEPTIC 0215 CARBIDOPA 0258 CHLORAZEPATE DIPOTASSIUM 0216 CARBIDOPA LEVODOPA 0259 CHLORDIAZEPOXIDE 0217 CARDENE 0260 CHLORDIAZEPOXIDE HCL 0218 CARDENZ 0261 CHLOROPHYLLIN COPPER 0219 CARDIOFLOW 0262 CHLOROTHIAZIDE 0220 CARDIZEM 0263 CHLORPHENIRAMINE MAL NIA/NINR-REACH II All rights reserved (V1.30) Med-list 11/23/04 Page 3 of 18 CODE Medication Name CODE Medication Name 0264 CHLORPROMAZINE 0309 COL PROBINECID 0265 CHLORPROPAMIDE 0310 COLACE 0266 CHLORTHALIDONE 0311 COLCHICINE 0267 CHLOR-TRIMETON 0312 COLD-GEST COLD CAPSULE 0268 CHLORZOXAZONE 0313 COLESTID 0269 CHOLAC 0314 COLLODIAL MINERAL 1825 CHOLESTYRAMINE 0315 COLLODIAL SILVER 0270 CHOLINE 0316 COLON CLEANSE 0271 CHOLINE MAGNESIUM TR 1789 COLOSTRUM 1574 CHOLORHEXIDINE 1827 COLYTE 0272 CHONDROITIN SULFATE 0317 COMBIVENT 0273 CHONDROITINASE 0318 COMPAT 0274 CHROMAGEN 0319 COMPAZINE 0275 CHROMIUM 1581 COMTAN 0276 CHROMIUM PICOLINATE 1582 COMTREX 0277 CILIUM 0320 CONJUGATED ESTROGENS 0278 CILOXAN 0321 CONSTULOSE 0279 CIMETIDINE 0322 CONTRIN 0280 CIPRO 0323 COPAXONE 0281 CIPROFLOXACIN 0324 CORDARONE 0282 CISAPRIDE 0325 CORDRAN TAPE 1575 CITALOPRAM 0326 COREG 1576 CITALOPRAM HYDROBROMIDE 0327 COREG POWDER 0283 CITRACAL 0328 CORGARD 0284 CITRUCEL 0329 CORRECTOL 1577 CLARINEX 1583 CORTEF 0285 CLARITIN 0330 CORTISOL 0286 CLARITIN-D 0331 CORTISPORIN 0287 CLEMASTINE 0332 CORTIZONE 0288 CLEOCIN 0333 CORVENT 0289 CLIDINIUM 1584 CORZIDE 0290 CLIDINIUM BROMIDE 0334 COSAMIN DS 0291 CLIMARA 0335 COSOPT 0292 CLINDAMYCIN HCL 0336 COUGH SYRUP 0293 CLINORIL 0337 COUGH X 1578 CLOMIPRAMINE 0338 COUMADIN 0294 CLONAZEPAM 0339 COVERA HS 1579 CLONIDINE 0340 COZAAR 0295 CLONIDINE HCL 0341 CRANBERRY EXTRACT 1826 CLOPIDOGREL 0342 CREATININE 0296 CLORAZEPATE 0343 CREON 0297 CLORAZEPATE DIPOTASSIUM 1828 CRESTOR 0298 CLORAZEPATE MONOPOTASSIUM 1762 CRIXIVAN 0299 CLOTRIMAZOLE 0344 CROLOM 0300 CLOZAPINE 0345 CUTIVATE 0301 CLOZARIL 0346 CYANOCOBALAMIN 0302 COD LIVER OIL 0347 CYANOCOBALAMIN USP 0303 CODEINE 0348 CYCLOBENZAPRINE 0304 CODEINE COMBINATIONS 0349 CYCLOGYL 0305 CODEINE USP 0350 CYCRIN 1580 COENZYME Q-10 0351 CYLERT 0306 COENZYME Q-10 0352 CYPROHEPTADINE HCL 0307 COGENTIN 0353 CYSTOSPAZ 0308 COGNEX 0354 CYTOMEL NIA/NINR-REACH II All rights reserved (V1.30) Med-list 11/23/04 Page 4 of 18 CODE Medication Name CODE Medication Name 0355 CYTOTEC 0402 DIGITOXINE 1585 CYTRA-2 0403 DIGOXIN 0356 DAILY VITAMINS 0404 DILACOR XR 0357 DAILY-VITE 0405 DILAMINATE 0358 DALMANE 0406 DILANTIN 0359 DAMASON-P 0407 DILATRATE SR 0360 DANAZOL 1830 DILTIAZEM 0361 DANDALION ROOT 0408 DILTIAZEM HCL 0362 DANTRIUM 0409 DIMETAPP 0363 DARVOCET-N 0410 DIOCTO 0364 DARVON 0411 DIOVAN 0365 DAYPRO 1590 DIPENTUM 0366 DDS 0412 DIPHEDRYL 0367 DEBA 0413 DIPHENENOXYLATE HCL 0368 DECADRON 0414 DIPHENHYDRAMINE HCL 0369 DECLOMYCIN 0415 DIPHENOXYLATE 0370 DECONAMINE 0416 DIPIVEFRIN HCL 0371 DECONGESTANT EXPECTO 1832 DIPRIVAN 0372 DECONSAL II CAPSULES 0417 DIPROLENE AF 0373 DELACORT 0418 DIPYRIDAMOLE 0374 DELTASONE 0419 DISALCID 0375 DEMADEX 0420 DISOPYRAMIDE PHOSPHA 0376 DEPAKENE 0421 DITROPAN 0377 DEPAKOTE 0422 DITROPAN TAB 1586 DEPO-PROVERA 0423 DIURIL 0378 DERIACTIN 0424 DIVALPROEX 0379 DESENEX 0425 DIVALPROEX SODIUM 0380 DESIPRAMINE 0426 DIXON-SHANE 0381 DESITIN 0427 DM COUGH SYRUP 0382 DESOGEN 0428 DOCTYLAX 0383 DESYREL 1591 DOCUSATE 0384 DETERENOL HCL 0429 DOCUSATE CALCIUM 0385 DETROL 0430 DOCUSATE POTASSIUM 1763 DEXCHLORPHENIRAMINE 0431 DOCUSATE SODIUM 0386 DEXEDRINE 1592 DOMPERIDONE 0387 DHEA 0432 DONEPEZIL 0388 DIABETA 0433 DONNATAL 0389 DIABINESE 0434 DOPA SINEMET 0390 DIALYTE 0435 DORAL 0391 DIAMOX 1833 DORZOLAMIDE 0392 DIAZEPAM 0436 DOUBLE X 0393 DIAZOXIDE 0437 DOUBLE X VITAMIN 0394 DIBROMM 0438 DOVONEX 0395 DICLOFENAC 1593 DOXAPIN 0396 DICLOFENAC SODIUM 0439 DOXAZOSIN MESYLATE 1829 DICLOXACILLIN 0440 DOXEPIN HCL 0397 DICYCLOMINE HCL 0441 DOXIN-SHANE 0398 DIENESTROL 0442 DOXYCYCLINE 1587 DIETARY SUPPLEMENT 0443 DRAMAMINE 0399 DIFALPROEX SODIUM 0444 DRIXORAL 0400 DIFLUCAN 0445 DRIZE 0401 DIFLUNISAL 0446 DSS 1588 DIGESTIVE AID 0447 DSS DIX DIXON 1589 DIGITEK 0448 DULCOLAX NIA/NINR-REACH II All rights reserved (V1.30) Med-list 11/23/04 Page 5 of 18 CODE Medication Name CODE Medication Name 0449 DUODERM 0494 EQUAL 0450 DUO-SET 1837 EQUATE 0451 DUPHALAC 0495 ERGOLOID 0452 DURACT 0496 ERY-TAB 0453 DURAGEN 0497 ERYTHRITYL TETRNITR
Load more

Recommended publications
  • Chapter 7: MLM's Abysmal Numbers
    7-1 The Case (for and) against Multi-level Marketing By Jon M. Taylor, MBA, Ph.D., Consumer Awareness Institute Chapter 7: MLM’s ABYSMAL NUMBERS Chapter summary a large enough downline to meet expenses, and therefore do not profit. Is MLM a profitable business These conclusions were confirmed in the opportunity? And if so, for whom? Just do the average earnings reports of all 30 MLMs for math – the numbers don't lie. In this and which we were able to obtain data published preceding chapters, you will find the most by the companies themselves. Such statistics rigorous and thorough analysis of MLM are invaluable for analysts to debunk the profitability ever done by an independent many misrepresentations that are told to research firm. Questions about the viability thousands of prospects every day. and profitability of MLM as a business model Failure and loss rates for MLMs are not and its many company manifestations are comparable with legitimate small answered in this and prior chapters – based businesses, which have been found to be on 15 years’ research, worldwide feedback, profitable for 39% over the lifetime of the and analysis of the compensation plans of business; whereas less than 1% of MLM over 350 of the leading MLMs, as well as participants profit. MLM makes even average earnings data, where available. The gambling look like a safe bet in comparison. answers are not pretty. MLM stocks are questionable Our studies, along with those done by investments at best. And like gambling, other independent analysts (not connected to losses from MLM participation should not be the MLM industry), clearly prove that MLM as a allowed as a tax deduction – beyond the business model – with its endless chain of amount of actual income.
    [Show full text]
  • The Management of Common Skin Conditions in General Practice
    Management of Common Skin Conditions In General Practice including the “red rash made easy” © Arroll, Fishman & Oakley, Department of General Practice and Primary Health Care University of Auckland, Tamaki Campus Reviewed by Hon A/Prof Amanda Oakley - 2019 http://www.dermnetnz.org Management of Common Skin Conditions In General Practice Contents Page Derm Map 3 Classic location: infants & children 4 Classic location: adults 5 Dermatology terminology 6 Common red rashes 7 Other common skin conditions 12 Common viral infections 14 Common bacterial infections 16 Common fungal infections 17 Arthropods 19 Eczema/dermatitis 20 Benign skin lesions 23 Skin cancers 26 Emergency dermatology 28 Clinical diagnosis of melanoma 31 Principles of diagnosis and treatment 32 Principles of treatment of eczema 33 Treatment sequence for psoriasis 34 Topical corticosteroids 35 Combination topical steroid + antimicrobial 36 Safety with topical corticosteroids 36 Emollients 37 Antipruritics 38 For further information, refer to: http://www.dermnetnz.org And http://www.derm-master.com 2 © Arroll, Fishman & Oakley, Department of General Practice and Primary Health Care, University of Auckland, Tamaki Campus. Management of Common Skin Conditions In General Practice DERM MAP Start Is the patient sick ? Yes Rash could be an infection or a drug eruption? No Insect Bites – Crop of grouped papules with a central blister or scab. Is the patient in pain or the rash Yes Infection: cellulitis / erysipelas, impetigo, boil is swelling, oozing or crusting? / folliculitis, herpes simplex / zoster. Urticaria – Smooth skin surface with weals that evolve in minutes to hours. No Is the rash in a classic location? Yes See our classic location chart .
    [Show full text]
  • PROVERA Medroxyprogesterone Acetate Tablets 2.5Mg, 5Mg, 10Mg, 100 Mg, 200 Mg Tablets
    PROVERA Medroxyprogesterone acetate tablets 2.5mg, 5mg, 10mg, 100 mg, 200 mg tablets What is in this leaflet establish a regular menstrual breast cancer or breast lumps cycle not diagnosed by your doctor This leaflet answers some common bleeding or discharge from questions about PROVERA. It does certain types of cancer including your nipples not contain all the available cancer of the breast, kidney and information. It does not take the endometrium (the lining of the miscarriage place of talking to your doctor or womb). pharmacist. cancer of the womb or ovary PROVERA, in combination with an uncontrolled high blood estrogen containing medicine, is All medicines have risks and pressure. benefits. Your doctor has weighed used to relieve symptoms of the risks of you taking PROVERA menopause in women with an intact Do not take PROVERA if you are against the benefits it is expected to uterus. This is called hormone pregnant or intend to become have for you. replacement therapy (HRT). pregnant. PROVERA is used to protect the If you have any concerns about lining of the uterus while the PROVERA may affect your taking this medicine, ask your estrogens relieve the symptoms of developing baby if you take it doctor or pharmacist. Keep this menopause. PROVERA is not during pregnancy. leaflet with your medicine. suitable as a HRT treatment in women who have undergone a Do not take PROVERA if the You may need to read it again. hysterectomy. packaging is torn or shows signs of tampering. Do not take Your doctor may have prescribed PROVERA after the expiry date What PROVERA is PROVERA for another purpose.
    [Show full text]
  • Liquid Spray Formulations for Buccal Delivery of Cannabinoids
    (19) TZZ_¥__T (11) EP 1 361 864 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 9/08 (2006.01) A61K 9/107 (2006.01) 04.12.2013 Bulletin 2013/49 A61K 36/185 (2006.01) (21) Application number: 02712063.3 (86) International application number: PCT/GB2002/000620 (22) Date of filing: 14.02.2002 (87) International publication number: WO 2002/064109 (22.08.2002 Gazette 2002/34) (54) LIQUID SPRAY FORMULATIONS FOR BUCCAL DELIVERY OF CANNABINOIDS FLÜSSIGE SPRAY FORMULIERUNGEN ZUR BUCCALEN VERABREICHUNG VON CANNABINOIDEN PREPARATIONS DE SPRAY LIQUIDE POUR L’ADMINISTRATION BUCCALE DE CANNABINOIDES (84) Designated Contracting States: (74) Representative: Schiller, Dominic Christopher et AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU al MC NL PT SE TR Harrison Goddard Foote LLP Designated Extension States: 4th Floor, Merchant Exchange RO SI 17-19 Whitworth Street West Manchester M1 5WG (GB) (30) Priority: 14.02.2001 GB 0103638 30.03.2001 US 280044 P (56) References cited: 05.04.2001 US 827158 WO-A-00/25127 WO-A-01/66089 11.05.2001 GB 0111597 WO-A-95/25504 WO-A1-02/32420 07.09.2001 GB 0121715 WO-A1-02/069993 US-A- 3 560 625 12.09.2001 US 951022 • EITAN ALHANATY; ET AL.: "Osmotic fragility of (43) Date of publication of application: liposomes as affected by antihemolytic 19.11.2003 Bulletin 2003/47 compounds" BIOCHIMICA ET BIOPHYSICA ACTA, vol. 339, no. 1, 1974, pages 146-155, (60) Divisional application: XP008008726 10180611.5 / 2 286 793 • PATRICIA S.
    [Show full text]
  • Student Members of the American Chemical Society Poster Presentation Event November 6, 2020 5:30 - 7:00 Pm Stonecipher Lecture Hall
    Student Members of the American Chemical Society Poster Presentation Event November 6, 2020 5:30 - 7:00 pm Stonecipher Lecture Hall Author: Brooke Underwood*, Courtney LaPointe, Dr. Jeffrey Boles Contact information: [email protected] Title: Liquid-liquid extraction and ultraviolet visible spectroscopy methods for distinguishing between hemp and marijuana Abstract: In December 2018, cannabis containing less than 0.3% tetrahydrocannabinol (THC), otherwise known as hemp, became legalized due to passage of the Farm Bill (1). This creates problems for law enforcement since current presumptive test kits either 1) don’t work at all or 2) work somewhat in differentiating between legal and illegal hemp crops. This problem exists because most hemp crops and hemp products contain low levels of THC and the carboxylated form, THCA. Our approach involves the advancement of an efficient, mobile, liquid-liquid extraction (LLE) that provides presumptive, qualitative forensic evidence of the chemical extract of a bud or other plant material. This research is focused on developing a kit that functions in a similar manner to NIK kits, commonly used by law enforcement, where all components of the kit are contained within a bag. The current NIK kit for Marijuana provides a false positive when Hemp is placed in the bag, thus creating the need for a more reliable test (2). The evidence would later be sent to a crime lab for definitive analysis and quantitation of THC by ultraviolet-visible spectroscopy (UV-vis). This research has focused on the utilization of liquid-liquid extraction techniques and commercially available stains. The methods presented are rapid (requiring no more than five to six minutes to complete).
    [Show full text]
  • List of Union Reference Dates A
    Active substance name (INN) EU DLP BfArM / BAH DLP yearly PSUR 6-month-PSUR yearly PSUR bis DLP (List of Union PSUR Submission Reference Dates and Frequency (List of Union Frequency of Reference Dates and submission of Periodic Frequency of submission of Safety Update Reports, Periodic Safety Update 30 Nov. 2012) Reports, 30 Nov.
    [Show full text]
  • Novel Derivatives of Bio-Affecting Phenolic Compounds and Pharmaceutical Composition Containing Them
    Europaisches Patentamt European Patent Office © Publication number: 0046 270 A1 Office europeen des brevets ™ EUROPEAN PATENT APPLICATION @ Application number: 81106277.7 © Int. CI.3: C 07 C 103/78, C 07 C 93/26, C 07 C 69/24, C 07 C 1 53/07, @ Date of filing: 12.08.81 C07C 69/28 // C07C1 25/065 <§) Priority: 13.08.80 US 177825 © Applicant: INTERx RESEARCH CORPORATION, 2201 West 21 st Street, Lawrence Kansas 66044 (US) © I nventor : Bodor, Nicholas S., 31 5 Southwest 91 st Street, ® Dateofpublicationofapplication:24.02.82 S^^S^mHariMBM Bulletin m/b Terrace, Gainesville, Florida 32605 (US) Inventor: Pogany, Stefano A., 520 Louisiana Street, Lawrence Kansas 66044 (US) @ Designated Contracting States : AT BE CH DE FR GB IT ® Representative: Abitz, Walter, Dr.-lng. et al, Abitz, Mori, LI LU NL SE Gritschneder P.O. Box 86 01 09, D-8000 Munchen 86 (DE) Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them. Novel@ Novel transient prodrug forms of bio-affecting phe- amyl, CH2ONO2,CH2ON02, -CH2OCOR2 or any non-heterocyclic nolic compounds are selected from the group consisting of member of the group defined by R2Rz above; and n.isn is at least those having the structural formula (I): one and equals the total number of phenolic hydroxyl functions comprising the non-steroidal bioaffecting phenol o etherified via a R2COXCH(R3)0-moiety; those having the structural formula (II): R2-C-X-CH-0- (I) I O R, II R2-C-X-CH-0- -RM-i-O-C-R2 (II) wherein X is O, S or NR5 wherein R5 is hydrogen or lower alkyl;alky!;
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Treatment of Diseases and Conditions Mediated By
    (19) TZZ_ ___T (11) EP 1 572 115 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 38/07 (2006.01) A61K 38/08 (2006.01) 21.01.2015 Bulletin 2015/04 A61K 38/17 (2006.01) A61K 38/38 (2006.01) (21) Application number: 03799853.1 (86) International application number: PCT/US2003/037901 (22) Date of filing: 25.11.2003 (87) International publication number: WO 2004/050023 (17.06.2004 Gazette 2004/25) (54) TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY INCREASED PHOSPHORYLATION BEHANDLUNG VON ERKRANKUNGEN UND ZUSTÄNDEN,DIE DURCH ERHÖHTE PHOSPHORYLIERUNG VERMITTELT WERDEN TRAITEMENT DE MALADIES ET D’ETATS A MEDIATION DE PHOSPHORYLATION ACCRUE (84) Designated Contracting States: • JIANG B ET AL: "Phosphopeptides derived from AT BE BG CH CY CZ DE DK EE ES FI FR GB GR hen egg yolk phosvitin: effect of molecular size HU IE IT LI LU MC NL PT RO SE SI SK TR on the calcium-binding properties." BIOSCIENCE, BIOTECHNOLOGY, AND (30) Priority: 27.11.2002 US 429924 P BIOCHEMISTRY MAY 2001, vol. 65, no. 5, May 2001 (2001-05), pages 1187-1190, XP002549556 (43) Date of publication of application: ISSN: 0916-8451 14.09.2005 Bulletin 2005/37 • KATAYAMA SHIGERU ET AL: "Antioxidative stress activity of oligophosphopeptides derived (73) Proprietor: Ampio Pharmaceuticals, Inc. from hen egg yolk phosvitin in Caco-2 cells." Englewood, CO 80112 (US) JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 8 FEB 2006, vol. 54, no. 3, 8 February (72) Inventor: BAR-OR, David 2006 (2006-02-08), pages 773-778, XP002549557 Englewood, CO 80110 (US) ISSN: 0021-8561 • OKAMOTO ET AL: ’The interleukin-8 AP-1 and (74) Representative: Weber, Joachim kappa B-like sites are genetic end targets of Hoefer & Partner FK506-sensitive pathway accompanied by Patentanwälte calcium mobilization.’ JOURNAL OF Pilgersheimer Strasse 20 BIOLOGICAL CHEMISTRY vol.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • COMPLETE® Vanilla
    Nutrition Information Per 100g Per serving % GDAb powder (prepared)a Energy 1614kJ 942kJ 383kcal 223kcal ® Fat 6.9g 2.6g of which saturates 0.9g 0.3g COMPLETE of which monounsaturates 2.2g 0.7g Meal Replacement for weight control. VanillaRecommended consumption: of which polyunsaturates 3.6g 1.7g Vanilla Milk Shake Powder. Replace a maximum of 2 meals per day with 1 serving each of Carbohydrate 44.5g 28.2g Juice PLUS+® COMPLETE. of which sugars 40.0g 26.6g Ingredients: Fibre 10.5g 3.7g Vegetable protein mix (from soya, soya tofu, rice, chickpeas), fruc- Preparation: Protein 30.5g 19.8g Stir one scoop (35g) of powder into 250ml of skimmed milk using tose, fibre mix oat( bran, cellulose, rice bran, pectin, apple fibre), a fork or whisk or prepare in a shaker. The shake can also be mixed Salt 1.42g 0.84g soya lecithin, thickeners (guar gum, carrageenan), sunflower oil, with a milk frother or a hand-held blender. Wait 1 minute before Calcium 86mg 338mg 42 flavourings, vitamin mix (vitamin A, vitamin D, vitamin E, folic drinking. Adding 2-3 ice cubes makes Juice PLUS+® COMPLETE taste Phosphorus 838mg 536mg 77 acid, niacin, pantothenic acid, vitamin B1, vitamin B2, vitamin B6, even creamier! Potassium 1528mg 910mg 46 vitamin C), mineral mix (copper, iron, magnesium, manganese, It is important that you follow these instructions when preparing Magnesium 24.4mg 55mg 15 potassium, selenium, zinc, iodine), rice maltodextrin, anticaking your COMPLETE Shake. Iron 13.4mg 5.0mg 36 agents: silicon dioxide, calcium silicate; fruit powder blend (apple, orange, pineapple, cranberry, peach, acerola cherry, papaya), Zinc 13.8mg 5.9mg 59 Please note: Copper 1.0mg 0.35mg 35 inulin, colouring (beta-carotene), vegetable powder blend (carrot, Juice PLUS+® COMPLETE provides the nutritional elements of a whole parsley, beet, broccoli, kale, cabbage, spinach, tomato), pineapple meal, delivering a balanced mix of carbohydrates, protein and fat, Iodine 160µg 65μg 43 powder, papaya powder, pumpkin seed flour, Norwegian kelp.
    [Show full text]
  • Vaginal Administration of Contraceptives
    Scientia Pharmaceutica Review Vaginal Administration of Contraceptives Esmat Jalalvandi 1,*, Hafez Jafari 2 , Christiani A. Amorim 3 , Denise Freitas Siqueira Petri 4 , Lei Nie 5,* and Amin Shavandi 2,* 1 School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK 2 BioMatter Unit, École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue F.D. Roosevelt, 50-CP 165/61, 1050 Brussels, Belgium; [email protected] 3 Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium; [email protected] 4 Fundamental Chemistry Department, Institute of Chemistry, University of São Paulo, Av. Prof. Lineu Prestes 748, São Paulo 05508-000, Brazil; [email protected] 5 College of Life Sciences, Xinyang Normal University, Xinyang 464000, China * Correspondence: [email protected] (E.J.); [email protected] (L.N.); [email protected] (A.S.); Tel.: +32-2-650-3681 (A.S.) Abstract: While contraceptive drugs have enabled many people to decide when they want to have a baby, more than 100 million unintended pregnancies each year in the world may indicate the contraceptive requirement of many people has not been well addressed yet. The vagina is a well- established and practical route for the delivery of various pharmacological molecules, including contraceptives. This review aims to present an overview of different contraceptive methods focusing on the vaginal route of delivery for contraceptives, including current developments, discussing the potentials and limitations of the modern methods, designs, and how well each method performs for delivering the contraceptives and preventing pregnancy.
    [Show full text]